FDA Publishes Updated Draft Guidance on Expanded Access to Investigational Drugs

December 6, 2022 | Strategic Insights for Ambulatory Care


​What's the news. The U.S. Food and Drug Administration (FDA) has published draft guidance on the agency's regulations on expanded access to investigational drugs for treatment use under an investigational new drug application, the agency says in a November 2022 guidance document.

Access Full Content

Contact us today at 610.825.6000.